nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR6—Alzheimer's disease	0.243	0.64	CbGaD
Iloperidone—SIGMAR1—Donepezil—Alzheimer's disease	0.159	0.43	CbGbCtD
Iloperidone—HTR2A—Alzheimer's disease	0.0714	0.188	CbGaD
Iloperidone—CYP2D6—Alzheimer's disease	0.0653	0.172	CbGaD
Iloperidone—HTR2A—Donepezil—Alzheimer's disease	0.0624	0.169	CbGbCtD
Iloperidone—DRD2—Memantine—Alzheimer's disease	0.0499	0.135	CbGbCtD
Iloperidone—CYP2D6—Rivastigmine—Alzheimer's disease	0.026	0.0703	CbGbCtD
Iloperidone—CYP2D6—Donepezil—Alzheimer's disease	0.0208	0.0562	CbGbCtD
Iloperidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0165	0.0447	CbGbCtD
Iloperidone—CYP2D6—Galantamine—Alzheimer's disease	0.0134	0.0362	CbGbCtD
Iloperidone—CYP3A4—Donepezil—Alzheimer's disease	0.0132	0.0357	CbGbCtD
Iloperidone—CYP3A4—Galantamine—Alzheimer's disease	0.00851	0.023	CbGbCtD
Iloperidone—HTR2C—choroid plexus—Alzheimer's disease	0.00651	0.112	CbGeAlD
Iloperidone—DRD3—telencephalic ventricle—Alzheimer's disease	0.00343	0.0591	CbGeAlD
Iloperidone—HTR2A—choroid plexus—Alzheimer's disease	0.00327	0.0563	CbGeAlD
Iloperidone—HTR7—locus ceruleus—Alzheimer's disease	0.00323	0.0558	CbGeAlD
Iloperidone—DRD1—telencephalic ventricle—Alzheimer's disease	0.00245	0.0423	CbGeAlD
Iloperidone—HTR2A—locus ceruleus—Alzheimer's disease	0.00202	0.0348	CbGeAlD
Iloperidone—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00193	0.0332	CbGeAlD
Iloperidone—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00191	0.0329	CbGeAlD
Iloperidone—HTR2A—cerebellar cortex—Alzheimer's disease	0.00164	0.0283	CbGeAlD
Iloperidone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00161	0.0277	CbGeAlD
Iloperidone—HTR7—telencephalic ventricle—Alzheimer's disease	0.00153	0.0264	CbGeAlD
Iloperidone—DRD2—telencephalic ventricle—Alzheimer's disease	0.00145	0.025	CbGeAlD
Iloperidone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000957	0.0165	CbGeAlD
Iloperidone—HTR1D—blood vessel—Alzheimer's disease	0.000953	0.0164	CbGeAlD
Iloperidone—HTR6—forebrain—Alzheimer's disease	0.000862	0.0149	CbGeAlD
Iloperidone—HTR6—telencephalon—Alzheimer's disease	0.000792	0.0137	CbGeAlD
Iloperidone—HTR7—blood vessel—Alzheimer's disease	0.000759	0.0131	CbGeAlD
Iloperidone—DRD1—forebrain—Alzheimer's disease	0.000641	0.011	CbGeAlD
Iloperidone—DRD1—telencephalon—Alzheimer's disease	0.000589	0.0102	CbGeAlD
Iloperidone—DRD4—brain—Alzheimer's disease	0.000528	0.00911	CbGeAlD
Iloperidone—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000521	0.00404	CcSEcCtD
Iloperidone—Cataract—Rivastigmine—Alzheimer's disease	0.000515	0.00399	CcSEcCtD
Iloperidone—Gait disturbance—Memantine—Alzheimer's disease	0.000513	0.00398	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.000513	0.00397	CcSEcCtD
Iloperidone—Dry eye—Donepezil—Alzheimer's disease	0.00051	0.00395	CcSEcCtD
Iloperidone—HTR1D—forebrain—Alzheimer's disease	0.000503	0.00867	CbGeAlD
Iloperidone—Gait disturbance—Rivastigmine—Alzheimer's disease	0.000502	0.00389	CcSEcCtD
Iloperidone—HTR2C—forebrain—Alzheimer's disease	0.000498	0.00858	CbGeAlD
Iloperidone—Urinary retention—Galantamine—Alzheimer's disease	0.000491	0.00381	CcSEcCtD
Iloperidone—DRD3—nervous system—Alzheimer's disease	0.000486	0.00838	CbGeAlD
Iloperidone—Urinary incontinence—Memantine—Alzheimer's disease	0.000484	0.00375	CcSEcCtD
Iloperidone—Dehydration—Galantamine—Alzheimer's disease	0.000481	0.00372	CcSEcCtD
Iloperidone—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000476	0.00369	CcSEcCtD
Iloperidone—HTR2A—blood vessel—Alzheimer's disease	0.000473	0.00816	CbGeAlD
Iloperidone—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.000473	0.00367	CcSEcCtD
Iloperidone—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000472	0.00366	CcSEcCtD
Iloperidone—Hypokalaemia—Galantamine—Alzheimer's disease	0.00047	0.00364	CcSEcCtD
Iloperidone—DRD3—central nervous system—Alzheimer's disease	0.000468	0.00806	CbGeAlD
Iloperidone—HTR6—nervous system—Alzheimer's disease	0.000468	0.00806	CbGeAlD
Iloperidone—Fluid retention—Rivastigmine—Alzheimer's disease	0.000465	0.0036	CcSEcCtD
Iloperidone—HTR1D—telencephalon—Alzheimer's disease	0.000462	0.00797	CbGeAlD
Iloperidone—HTR2C—telencephalon—Alzheimer's disease	0.000458	0.00789	CbGeAlD
Iloperidone—Gastritis—Galantamine—Alzheimer's disease	0.000457	0.00354	CcSEcCtD
Iloperidone—Mouth ulceration—Memantine—Alzheimer's disease	0.000453	0.00351	CcSEcCtD
Iloperidone—HTR6—central nervous system—Alzheimer's disease	0.00045	0.00776	CbGeAlD
Iloperidone—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.000443	0.00343	CcSEcCtD
Iloperidone—Libido decreased—Donepezil—Alzheimer's disease	0.000432	0.00335	CcSEcCtD
Iloperidone—SIGMAR1—telencephalon—Alzheimer's disease	0.000431	0.00743	CbGeAlD
Iloperidone—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000428	0.00332	CcSEcCtD
Iloperidone—Increased appetite—Donepezil—Alzheimer's disease	0.000426	0.0033	CcSEcCtD
Iloperidone—Thirst—Donepezil—Alzheimer's disease	0.000421	0.00326	CcSEcCtD
Iloperidone—HTR1A—forebrain—Alzheimer's disease	0.000419	0.00722	CbGeAlD
Iloperidone—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000415	0.00322	CcSEcCtD
Iloperidone—Pollakiuria—Galantamine—Alzheimer's disease	0.000413	0.0032	CcSEcCtD
Iloperidone—Paliperidone—HTR2A—Alzheimer's disease	0.000411	0.19	CrCbGaD
Iloperidone—Cardiac failure—Donepezil—Alzheimer's disease	0.00041	0.00318	CcSEcCtD
Iloperidone—Weight decreased—Galantamine—Alzheimer's disease	0.000404	0.00313	CcSEcCtD
Iloperidone—HTR7—forebrain—Alzheimer's disease	0.000401	0.0069	CbGeAlD
Iloperidone—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000397	0.00308	CcSEcCtD
Iloperidone—Affect lability—Donepezil—Alzheimer's disease	0.000394	0.00305	CcSEcCtD
Iloperidone—Renal failure acute—Memantine—Alzheimer's disease	0.000394	0.00305	CcSEcCtD
Iloperidone—Libido decreased—Memantine—Alzheimer's disease	0.000392	0.00304	CcSEcCtD
Iloperidone—Psychotic disorder—Donepezil—Alzheimer's disease	0.000391	0.00303	CcSEcCtD
Iloperidone—Amnesia—Memantine—Alzheimer's disease	0.000387	0.003	CcSEcCtD
Iloperidone—Increased appetite—Memantine—Alzheimer's disease	0.000387	0.003	CcSEcCtD
Iloperidone—ADRA1A—forebrain—Alzheimer's disease	0.000386	0.00666	CbGeAlD
Iloperidone—HTR1A—telencephalon—Alzheimer's disease	0.000385	0.00664	CbGeAlD
Iloperidone—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000385	0.00299	CcSEcCtD
Iloperidone—Libido decreased—Rivastigmine—Alzheimer's disease	0.000384	0.00297	CcSEcCtD
Iloperidone—Urinary retention—Donepezil—Alzheimer's disease	0.000381	0.00295	CcSEcCtD
Iloperidone—Mood swings—Donepezil—Alzheimer's disease	0.000379	0.00294	CcSEcCtD
Iloperidone—DRD2—forebrain—Alzheimer's disease	0.000379	0.00653	CbGeAlD
Iloperidone—Amnesia—Rivastigmine—Alzheimer's disease	0.000379	0.00293	CcSEcCtD
Iloperidone—Increased appetite—Rivastigmine—Alzheimer's disease	0.000379	0.00293	CcSEcCtD
Iloperidone—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000377	0.00292	CcSEcCtD
Iloperidone—Paliperidone—CYP2D6—Alzheimer's disease	0.000376	0.174	CrCbGaD
Iloperidone—Epistaxis—Galantamine—Alzheimer's disease	0.000376	0.00291	CcSEcCtD
Iloperidone—Thirst—Rivastigmine—Alzheimer's disease	0.000374	0.0029	CcSEcCtD
Iloperidone—Cardiac failure—Memantine—Alzheimer's disease	0.000373	0.00289	CcSEcCtD
Iloperidone—Dehydration—Donepezil—Alzheimer's disease	0.000372	0.00289	CcSEcCtD
Iloperidone—DRD3—brain—Alzheimer's disease	0.000371	0.0064	CbGeAlD
Iloperidone—Lethargy—Memantine—Alzheimer's disease	0.000371	0.00288	CcSEcCtD
Iloperidone—HTR7—telencephalon—Alzheimer's disease	0.000368	0.00635	CbGeAlD
Iloperidone—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000366	0.00283	CcSEcCtD
Iloperidone—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000365	0.00282	CcSEcCtD
Iloperidone—Hypokalaemia—Donepezil—Alzheimer's disease	0.000365	0.00282	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000361	0.0028	CcSEcCtD
Iloperidone—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000358	0.00277	CcSEcCtD
Iloperidone—Affect lability—Memantine—Alzheimer's disease	0.000358	0.00277	CcSEcCtD
Iloperidone—HTR6—brain—Alzheimer's disease	0.000358	0.00616	CbGeAlD
Iloperidone—ADRA1A—telencephalon—Alzheimer's disease	0.000355	0.00612	CbGeAlD
Iloperidone—Psychotic disorder—Memantine—Alzheimer's disease	0.000355	0.00275	CcSEcCtD
Iloperidone—Gastritis—Donepezil—Alzheimer's disease	0.000354	0.00275	CcSEcCtD
Iloperidone—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000353	0.00274	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000353	0.00273	CcSEcCtD
Iloperidone—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000351	0.00272	CcSEcCtD
Iloperidone—Urethral disorder—Galantamine—Alzheimer's disease	0.00035	0.00272	CcSEcCtD
Iloperidone—Affect lability—Rivastigmine—Alzheimer's disease	0.00035	0.00271	CcSEcCtD
Iloperidone—DRD2—telencephalon—Alzheimer's disease	0.000348	0.006	CbGeAlD
Iloperidone—DRD1—nervous system—Alzheimer's disease	0.000348	0.006	CbGeAlD
Iloperidone—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000347	0.00269	CcSEcCtD
Iloperidone—Asthma—Donepezil—Alzheimer's disease	0.000346	0.00268	CcSEcCtD
Iloperidone—Urinary retention—Memantine—Alzheimer's disease	0.000346	0.00268	CcSEcCtD
Iloperidone—Mood swings—Memantine—Alzheimer's disease	0.000345	0.00267	CcSEcCtD
Iloperidone—ADRA2C—telencephalon—Alzheimer's disease	0.000339	0.00584	CbGeAlD
Iloperidone—Urinary retention—Rivastigmine—Alzheimer's disease	0.000338	0.00262	CcSEcCtD
Iloperidone—Dehydration—Memantine—Alzheimer's disease	0.000338	0.00262	CcSEcCtD
Iloperidone—Mood swings—Rivastigmine—Alzheimer's disease	0.000337	0.00261	CcSEcCtD
Iloperidone—DRD1—central nervous system—Alzheimer's disease	0.000335	0.00577	CbGeAlD
Iloperidone—Eye disorder—Galantamine—Alzheimer's disease	0.000334	0.00259	CcSEcCtD
Iloperidone—Tinnitus—Galantamine—Alzheimer's disease	0.000333	0.00258	CcSEcCtD
Iloperidone—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000332	0.00257	CcSEcCtD
Iloperidone—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000332	0.00257	CcSEcCtD
Iloperidone—Cardiac disorder—Galantamine—Alzheimer's disease	0.000332	0.00257	CcSEcCtD
Iloperidone—Hypokalaemia—Memantine—Alzheimer's disease	0.000331	0.00256	CcSEcCtD
Iloperidone—Dehydration—Rivastigmine—Alzheimer's disease	0.000331	0.00256	CcSEcCtD
Iloperidone—Nasopharyngitis—Memantine—Alzheimer's disease	0.000325	0.00252	CcSEcCtD
Iloperidone—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000325	0.00252	CcSEcCtD
Iloperidone—Angiopathy—Galantamine—Alzheimer's disease	0.000324	0.00251	CcSEcCtD
Iloperidone—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000324	0.00251	CcSEcCtD
Iloperidone—Dysuria—Donepezil—Alzheimer's disease	0.000324	0.00251	CcSEcCtD
Iloperidone—Gastritis—Memantine—Alzheimer's disease	0.000322	0.00249	CcSEcCtD
Iloperidone—Breast disorder—Rivastigmine—Alzheimer's disease	0.000321	0.00249	CcSEcCtD
Iloperidone—Pollakiuria—Donepezil—Alzheimer's disease	0.00032	0.00248	CcSEcCtD
Iloperidone—Arrhythmia—Galantamine—Alzheimer's disease	0.000319	0.00247	CcSEcCtD
Iloperidone—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000318	0.00246	CcSEcCtD
Iloperidone—Weight increased—Donepezil—Alzheimer's disease	0.000315	0.00244	CcSEcCtD
Iloperidone—Gastritis—Rivastigmine—Alzheimer's disease	0.000315	0.00244	CcSEcCtD
Iloperidone—Asthma—Memantine—Alzheimer's disease	0.000314	0.00244	CcSEcCtD
Iloperidone—Mental disorder—Galantamine—Alzheimer's disease	0.000313	0.00243	CcSEcCtD
Iloperidone—Weight decreased—Donepezil—Alzheimer's disease	0.000313	0.00243	CcSEcCtD
Iloperidone—Cisapride—HTR2A—Alzheimer's disease	0.000312	0.144	CrCbGaD
Iloperidone—Malnutrition—Galantamine—Alzheimer's disease	0.000311	0.00241	CcSEcCtD
Iloperidone—Risperidone—HTR2A—Alzheimer's disease	0.000307	0.142	CrCbGaD
Iloperidone—Conjunctivitis—Donepezil—Alzheimer's disease	0.0003	0.00232	CcSEcCtD
Iloperidone—Muscle spasms—Galantamine—Alzheimer's disease	0.000299	0.00232	CcSEcCtD
Iloperidone—HRH1—forebrain—Alzheimer's disease	0.000299	0.00516	CbGeAlD
Iloperidone—Dysuria—Memantine—Alzheimer's disease	0.000294	0.00228	CcSEcCtD
Iloperidone—ADRA2A—forebrain—Alzheimer's disease	0.000294	0.00506	CbGeAlD
Iloperidone—Vision blurred—Galantamine—Alzheimer's disease	0.000293	0.00227	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000292	0.00226	CcSEcCtD
Iloperidone—Tremor—Galantamine—Alzheimer's disease	0.000292	0.00226	CcSEcCtD
Iloperidone—Epistaxis—Donepezil—Alzheimer's disease	0.000291	0.00226	CcSEcCtD
Iloperidone—Pollakiuria—Memantine—Alzheimer's disease	0.00029	0.00225	CcSEcCtD
Iloperidone—Erectile dysfunction—Memantine—Alzheimer's disease	0.000289	0.00224	CcSEcCtD
Iloperidone—Anaemia—Galantamine—Alzheimer's disease	0.000288	0.00223	CcSEcCtD
Iloperidone—Dysuria—Rivastigmine—Alzheimer's disease	0.000288	0.00223	CcSEcCtD
Iloperidone—Weight increased—Memantine—Alzheimer's disease	0.000286	0.00222	CcSEcCtD
Iloperidone—Agitation—Galantamine—Alzheimer's disease	0.000286	0.00222	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000286	0.00221	CcSEcCtD
Iloperidone—Cisapride—CYP2D6—Alzheimer's disease	0.000285	0.132	CrCbGaD
Iloperidone—Weight decreased—Memantine—Alzheimer's disease	0.000284	0.0022	CcSEcCtD
Iloperidone—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000284	0.0022	CcSEcCtD
Iloperidone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000283	0.00219	CcSEcCtD
Iloperidone—HTR2A—embryo—Alzheimer's disease	0.000282	0.00487	CbGeAlD
Iloperidone—Risperidone—CYP2D6—Alzheimer's disease	0.00028	0.13	CrCbGaD
Iloperidone—Weight increased—Rivastigmine—Alzheimer's disease	0.00028	0.00217	CcSEcCtD
Iloperidone—Vertigo—Galantamine—Alzheimer's disease	0.00028	0.00217	CcSEcCtD
Iloperidone—Weight decreased—Rivastigmine—Alzheimer's disease	0.000278	0.00216	CcSEcCtD
Iloperidone—Palpitations—Galantamine—Alzheimer's disease	0.000275	0.00213	CcSEcCtD
Iloperidone—HRH1—telencephalon—Alzheimer's disease	0.000275	0.00474	CbGeAlD
Iloperidone—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000274	0.00212	CcSEcCtD
Iloperidone—HTR1D—nervous system—Alzheimer's disease	0.000273	0.00471	CbGeAlD
Iloperidone—Conjunctivitis—Memantine—Alzheimer's disease	0.000272	0.00211	CcSEcCtD
Iloperidone—Urethral disorder—Donepezil—Alzheimer's disease	0.000272	0.0021	CcSEcCtD
Iloperidone—HTR2C—nervous system—Alzheimer's disease	0.00027	0.00466	CbGeAlD
Iloperidone—ADRA2A—telencephalon—Alzheimer's disease	0.00027	0.00466	CbGeAlD
Iloperidone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000266	0.00206	CcSEcCtD
Iloperidone—DRD1—brain—Alzheimer's disease	0.000266	0.00458	CbGeAlD
Iloperidone—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000265	0.00205	CcSEcCtD
Iloperidone—Myalgia—Galantamine—Alzheimer's disease	0.000265	0.00205	CcSEcCtD
Iloperidone—Arthralgia—Galantamine—Alzheimer's disease	0.000265	0.00205	CcSEcCtD
Iloperidone—Epistaxis—Memantine—Alzheimer's disease	0.000264	0.00205	CcSEcCtD
Iloperidone—CYP2E1—telencephalon—Alzheimer's disease	0.000264	0.00456	CbGeAlD
Iloperidone—HTR1D—central nervous system—Alzheimer's disease	0.000263	0.00453	CbGeAlD
Iloperidone—HTR2C—central nervous system—Alzheimer's disease	0.00026	0.00449	CbGeAlD
Iloperidone—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000259	0.00201	CcSEcCtD
Iloperidone—Dry mouth—Galantamine—Alzheimer's disease	0.000259	0.00201	CcSEcCtD
Iloperidone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000259	0.002	CcSEcCtD
Iloperidone—Tinnitus—Donepezil—Alzheimer's disease	0.000258	0.002	CcSEcCtD
Iloperidone—Confusional state—Galantamine—Alzheimer's disease	0.000256	0.00198	CcSEcCtD
Iloperidone—HTR2A—forebrain—Alzheimer's disease	0.00025	0.00431	CbGeAlD
Iloperidone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000249	0.00193	CcSEcCtD
Iloperidone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000248	0.00192	CcSEcCtD
Iloperidone—Tachycardia—Galantamine—Alzheimer's disease	0.000248	0.00192	CcSEcCtD
Iloperidone—Arrhythmia—Donepezil—Alzheimer's disease	0.000248	0.00192	CcSEcCtD
Iloperidone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000247	0.00192	CcSEcCtD
Iloperidone—Urethral disorder—Memantine—Alzheimer's disease	0.000247	0.00191	CcSEcCtD
Iloperidone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000243	0.00188	CcSEcCtD
Iloperidone—Mental disorder—Donepezil—Alzheimer's disease	0.000243	0.00188	CcSEcCtD
Iloperidone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000242	0.00187	CcSEcCtD
Iloperidone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000241	0.00187	CcSEcCtD
Iloperidone—Malnutrition—Donepezil—Alzheimer's disease	0.000241	0.00187	CcSEcCtD
Iloperidone—SIGMAR1—cerebellum—Alzheimer's disease	0.00024	0.00413	CbGeAlD
Iloperidone—Hypotension—Galantamine—Alzheimer's disease	0.000237	0.00184	CcSEcCtD
Iloperidone—Eye disorder—Memantine—Alzheimer's disease	0.000235	0.00182	CcSEcCtD
Iloperidone—Tinnitus—Memantine—Alzheimer's disease	0.000235	0.00182	CcSEcCtD
Iloperidone—Cardiac disorder—Memantine—Alzheimer's disease	0.000233	0.00181	CcSEcCtD
Iloperidone—Muscle spasms—Donepezil—Alzheimer's disease	0.000232	0.0018	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000231	0.00179	CcSEcCtD
Iloperidone—Eye disorder—Rivastigmine—Alzheimer's disease	0.00023	0.00178	CcSEcCtD
Iloperidone—HTR2A—telencephalon—Alzheimer's disease	0.00023	0.00396	CbGeAlD
Iloperidone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000229	0.00178	CcSEcCtD
Iloperidone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000228	0.00177	CcSEcCtD
Iloperidone—Angiopathy—Memantine—Alzheimer's disease	0.000228	0.00177	CcSEcCtD
Iloperidone—Paraesthesia—Galantamine—Alzheimer's disease	0.000228	0.00177	CcSEcCtD
Iloperidone—CYP2D6—forebrain—Alzheimer's disease	0.000228	0.00392	CbGeAlD
Iloperidone—HTR1A—nervous system—Alzheimer's disease	0.000228	0.00392	CbGeAlD
Iloperidone—Vision blurred—Donepezil—Alzheimer's disease	0.000227	0.00176	CcSEcCtD
Iloperidone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000227	0.00176	CcSEcCtD
Iloperidone—Tremor—Donepezil—Alzheimer's disease	0.000226	0.00175	CcSEcCtD
Iloperidone—Somnolence—Galantamine—Alzheimer's disease	0.000226	0.00175	CcSEcCtD
Iloperidone—Arrhythmia—Memantine—Alzheimer's disease	0.000225	0.00174	CcSEcCtD
Iloperidone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000223	0.00173	CcSEcCtD
Iloperidone—Anaemia—Donepezil—Alzheimer's disease	0.000223	0.00173	CcSEcCtD
Iloperidone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000222	0.00172	CcSEcCtD
Iloperidone—Agitation—Donepezil—Alzheimer's disease	0.000222	0.00172	CcSEcCtD
Iloperidone—Mental disorder—Memantine—Alzheimer's disease	0.00022	0.00171	CcSEcCtD
Iloperidone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00022	0.0017	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000219	0.0017	CcSEcCtD
Iloperidone—HTR1A—central nervous system—Alzheimer's disease	0.000219	0.00378	CbGeAlD
Iloperidone—Malnutrition—Memantine—Alzheimer's disease	0.000219	0.0017	CcSEcCtD
Iloperidone—Fatigue—Galantamine—Alzheimer's disease	0.000219	0.0017	CcSEcCtD
Iloperidone—HTR7—nervous system—Alzheimer's disease	0.000217	0.00375	CbGeAlD
Iloperidone—Vertigo—Donepezil—Alzheimer's disease	0.000217	0.00168	CcSEcCtD
Iloperidone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000216	0.00167	CcSEcCtD
Iloperidone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000214	0.00166	CcSEcCtD
Iloperidone—HTR1A—cerebellum—Alzheimer's disease	0.000214	0.00369	CbGeAlD
Iloperidone—ADRA1A—nervous system—Alzheimer's disease	0.00021	0.00362	CbGeAlD
Iloperidone—HTR7—central nervous system—Alzheimer's disease	0.000209	0.00361	CbGeAlD
Iloperidone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000209	0.00162	CcSEcCtD
Iloperidone—CYP2D6—telencephalon—Alzheimer's disease	0.000209	0.00361	CbGeAlD
Iloperidone—HTR1D—brain—Alzheimer's disease	0.000209	0.0036	CbGeAlD
Iloperidone—HTR2C—brain—Alzheimer's disease	0.000207	0.00356	CbGeAlD
Iloperidone—Vision blurred—Memantine—Alzheimer's disease	0.000206	0.0016	CcSEcCtD
Iloperidone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000206	0.0016	CcSEcCtD
Iloperidone—DRD2—nervous system—Alzheimer's disease	0.000206	0.00354	CbGeAlD
Iloperidone—Myalgia—Donepezil—Alzheimer's disease	0.000205	0.00159	CcSEcCtD
Iloperidone—Arthralgia—Donepezil—Alzheimer's disease	0.000205	0.00159	CcSEcCtD
Iloperidone—Tremor—Memantine—Alzheimer's disease	0.000205	0.00159	CcSEcCtD
Iloperidone—HTR7—cerebellum—Alzheimer's disease	0.000205	0.00353	CbGeAlD
Iloperidone—Anaemia—Memantine—Alzheimer's disease	0.000202	0.00157	CcSEcCtD
Iloperidone—ADRA1A—central nervous system—Alzheimer's disease	0.000202	0.00348	CbGeAlD
Iloperidone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000202	0.00156	CcSEcCtD
Iloperidone—Agitation—Memantine—Alzheimer's disease	0.000201	0.00156	CcSEcCtD
Iloperidone—Dry mouth—Donepezil—Alzheimer's disease	0.000201	0.00156	CcSEcCtD
Iloperidone—Body temperature increased—Galantamine—Alzheimer's disease	0.000201	0.00156	CcSEcCtD
Iloperidone—Tremor—Rivastigmine—Alzheimer's disease	0.000201	0.00156	CcSEcCtD
Iloperidone—ADRA2C—nervous system—Alzheimer's disease	0.0002	0.00345	CbGeAlD
Iloperidone—Confusional state—Donepezil—Alzheimer's disease	0.000198	0.00154	CcSEcCtD
Iloperidone—Anaemia—Rivastigmine—Alzheimer's disease	0.000198	0.00153	CcSEcCtD
Iloperidone—DRD2—central nervous system—Alzheimer's disease	0.000198	0.00341	CbGeAlD
Iloperidone—ADRA1A—cerebellum—Alzheimer's disease	0.000197	0.0034	CbGeAlD
Iloperidone—Agitation—Rivastigmine—Alzheimer's disease	0.000197	0.00153	CcSEcCtD
Iloperidone—Oedema—Donepezil—Alzheimer's disease	0.000197	0.00153	CcSEcCtD
Iloperidone—Vertigo—Memantine—Alzheimer's disease	0.000197	0.00152	CcSEcCtD
Iloperidone—Leukopenia—Memantine—Alzheimer's disease	0.000196	0.00152	CcSEcCtD
Iloperidone—Infection—Donepezil—Alzheimer's disease	0.000196	0.00152	CcSEcCtD
Iloperidone—SIGMAR1—brain—Alzheimer's disease	0.000195	0.00335	CbGeAlD
Iloperidone—Palpitations—Memantine—Alzheimer's disease	0.000194	0.0015	CcSEcCtD
Iloperidone—DRD2—cerebellum—Alzheimer's disease	0.000193	0.00333	CbGeAlD
Iloperidone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000193	0.0015	CcSEcCtD
Iloperidone—Vertigo—Rivastigmine—Alzheimer's disease	0.000192	0.00149	CcSEcCtD
Iloperidone—ADRA2C—central nervous system—Alzheimer's disease	0.000192	0.00332	CbGeAlD
Iloperidone—Gefitinib—CYP2D6—Alzheimer's disease	0.000189	0.0877	CrCbGaD
Iloperidone—Palpitations—Rivastigmine—Alzheimer's disease	0.000189	0.00147	CcSEcCtD
Iloperidone—ADRA2C—cerebellum—Alzheimer's disease	0.000188	0.00324	CbGeAlD
Iloperidone—Myalgia—Memantine—Alzheimer's disease	0.000186	0.00144	CcSEcCtD
Iloperidone—Arthralgia—Memantine—Alzheimer's disease	0.000186	0.00144	CcSEcCtD
Iloperidone—Hypotension—Donepezil—Alzheimer's disease	0.000184	0.00143	CcSEcCtD
Iloperidone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000182	0.00141	CcSEcCtD
Iloperidone—Myalgia—Rivastigmine—Alzheimer's disease	0.000182	0.00141	CcSEcCtD
Iloperidone—Dry mouth—Memantine—Alzheimer's disease	0.000182	0.00141	CcSEcCtD
Iloperidone—Asthenia—Galantamine—Alzheimer's disease	0.000182	0.00141	CcSEcCtD
Iloperidone—Confusional state—Memantine—Alzheimer's disease	0.00018	0.0014	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000179	0.00139	CcSEcCtD
Iloperidone—Oedema—Memantine—Alzheimer's disease	0.000179	0.00138	CcSEcCtD
Iloperidone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000178	0.00138	CcSEcCtD
Iloperidone—Infection—Memantine—Alzheimer's disease	0.000178	0.00138	CcSEcCtD
Iloperidone—Paraesthesia—Donepezil—Alzheimer's disease	0.000177	0.00137	CcSEcCtD
Iloperidone—Confusional state—Rivastigmine—Alzheimer's disease	0.000176	0.00137	CcSEcCtD
Iloperidone—Dyspnoea—Donepezil—Alzheimer's disease	0.000176	0.00136	CcSEcCtD
Iloperidone—Nervous system disorder—Memantine—Alzheimer's disease	0.000175	0.00136	CcSEcCtD
Iloperidone—Somnolence—Donepezil—Alzheimer's disease	0.000175	0.00136	CcSEcCtD
Iloperidone—Oedema—Rivastigmine—Alzheimer's disease	0.000175	0.00135	CcSEcCtD
Iloperidone—Tachycardia—Memantine—Alzheimer's disease	0.000174	0.00135	CcSEcCtD
Iloperidone—HTR1A—brain—Alzheimer's disease	0.000174	0.003	CbGeAlD
Iloperidone—Diarrhoea—Galantamine—Alzheimer's disease	0.000174	0.00135	CcSEcCtD
Iloperidone—Infection—Rivastigmine—Alzheimer's disease	0.000174	0.00135	CcSEcCtD
Iloperidone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000171	0.00133	CcSEcCtD
Iloperidone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000171	0.00132	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00017	0.00132	CcSEcCtD
Iloperidone—Fatigue—Donepezil—Alzheimer's disease	0.00017	0.00131	CcSEcCtD
Iloperidone—Dizziness—Galantamine—Alzheimer's disease	0.000168	0.0013	CcSEcCtD
Iloperidone—Hypotension—Memantine—Alzheimer's disease	0.000167	0.00129	CcSEcCtD
Iloperidone—HTR7—brain—Alzheimer's disease	0.000166	0.00286	CbGeAlD
Iloperidone—Hypotension—Rivastigmine—Alzheimer's disease	0.000163	0.00127	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000163	0.00126	CcSEcCtD
Iloperidone—HRH1—nervous system—Alzheimer's disease	0.000162	0.0028	CbGeAlD
Iloperidone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000162	0.00126	CcSEcCtD
Iloperidone—Paraesthesia—Memantine—Alzheimer's disease	0.00016	0.00124	CcSEcCtD
Iloperidone—ADRA1A—brain—Alzheimer's disease	0.00016	0.00276	CbGeAlD
Iloperidone—Rash—Galantamine—Alzheimer's disease	0.00016	0.00124	CcSEcCtD
Iloperidone—Dermatitis—Galantamine—Alzheimer's disease	0.00016	0.00124	CcSEcCtD
Iloperidone—ADRA2A—nervous system—Alzheimer's disease	0.000159	0.00275	CbGeAlD
Iloperidone—Dyspnoea—Memantine—Alzheimer's disease	0.000159	0.00123	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000159	0.00123	CcSEcCtD
Iloperidone—Somnolence—Memantine—Alzheimer's disease	0.000159	0.00123	CcSEcCtD
Iloperidone—DRD2—brain—Alzheimer's disease	0.000157	0.00271	CbGeAlD
Iloperidone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000157	0.00122	CcSEcCtD
Iloperidone—HRH1—central nervous system—Alzheimer's disease	0.000156	0.00269	CbGeAlD
Iloperidone—CYP2E1—nervous system—Alzheimer's disease	0.000156	0.00269	CbGeAlD
Iloperidone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000156	0.00121	CcSEcCtD
Iloperidone—Body temperature increased—Donepezil—Alzheimer's disease	0.000156	0.00121	CcSEcCtD
Iloperidone—Somnolence—Rivastigmine—Alzheimer's disease	0.000155	0.0012	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000154	0.0012	CcSEcCtD
Iloperidone—Fatigue—Memantine—Alzheimer's disease	0.000154	0.00119	CcSEcCtD
Iloperidone—ADRA2A—central nervous system—Alzheimer's disease	0.000154	0.00265	CbGeAlD
Iloperidone—ADRA2C—brain—Alzheimer's disease	0.000153	0.00263	CbGeAlD
Iloperidone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000151	0.00117	CcSEcCtD
Iloperidone—Nausea—Galantamine—Alzheimer's disease	0.000151	0.00117	CcSEcCtD
Iloperidone—Fatigue—Rivastigmine—Alzheimer's disease	0.000151	0.00117	CcSEcCtD
Iloperidone—CYP2E1—central nervous system—Alzheimer's disease	0.00015	0.00259	CbGeAlD
Iloperidone—ADRA2A—cerebellum—Alzheimer's disease	0.00015	0.00259	CbGeAlD
Iloperidone—Feeling abnormal—Memantine—Alzheimer's disease	0.000147	0.00114	CcSEcCtD
Iloperidone—CYP2E1—cerebellum—Alzheimer's disease	0.000147	0.00253	CbGeAlD
Iloperidone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000144	0.00112	CcSEcCtD
Iloperidone—Body temperature increased—Memantine—Alzheimer's disease	0.000141	0.00109	CcSEcCtD
Iloperidone—Asthenia—Donepezil—Alzheimer's disease	0.000141	0.00109	CcSEcCtD
Iloperidone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000138	0.00107	CcSEcCtD
Iloperidone—HTR2A—nervous system—Alzheimer's disease	0.000136	0.00234	CbGeAlD
Iloperidone—Diarrhoea—Donepezil—Alzheimer's disease	0.000135	0.00104	CcSEcCtD
Iloperidone—HTR2A—central nervous system—Alzheimer's disease	0.000131	0.00225	CbGeAlD
Iloperidone—Dizziness—Donepezil—Alzheimer's disease	0.00013	0.00101	CcSEcCtD
Iloperidone—Asthenia—Memantine—Alzheimer's disease	0.000128	0.000994	CcSEcCtD
Iloperidone—HTR2A—cerebellum—Alzheimer's disease	0.000128	0.0022	CbGeAlD
Iloperidone—CYP3A4—nervous system—Alzheimer's disease	0.000126	0.00216	CbGeAlD
Iloperidone—Asthenia—Rivastigmine—Alzheimer's disease	0.000125	0.000972	CcSEcCtD
Iloperidone—Rash—Donepezil—Alzheimer's disease	0.000124	0.000962	CcSEcCtD
Iloperidone—HRH1—brain—Alzheimer's disease	0.000124	0.00214	CbGeAlD
Iloperidone—Dermatitis—Donepezil—Alzheimer's disease	0.000124	0.000961	CcSEcCtD
Iloperidone—CYP2D6—nervous system—Alzheimer's disease	0.000124	0.00213	CbGeAlD
Iloperidone—Diarrhoea—Memantine—Alzheimer's disease	0.000122	0.000947	CcSEcCtD
Iloperidone—ADRA2A—brain—Alzheimer's disease	0.000122	0.0021	CbGeAlD
Iloperidone—CYP3A4—central nervous system—Alzheimer's disease	0.000121	0.00208	CbGeAlD
Iloperidone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00012	0.000927	CcSEcCtD
Iloperidone—CYP2E1—brain—Alzheimer's disease	0.000119	0.00206	CbGeAlD
Iloperidone—CYP2D6—central nervous system—Alzheimer's disease	0.000119	0.00205	CbGeAlD
Iloperidone—Dizziness—Memantine—Alzheimer's disease	0.000118	0.000916	CcSEcCtD
Iloperidone—Nausea—Donepezil—Alzheimer's disease	0.000117	0.000906	CcSEcCtD
Iloperidone—CYP2D6—cerebellum—Alzheimer's disease	0.000116	0.002	CbGeAlD
Iloperidone—Dizziness—Rivastigmine—Alzheimer's disease	0.000116	0.000896	CcSEcCtD
Iloperidone—Rash—Memantine—Alzheimer's disease	0.000113	0.000873	CcSEcCtD
Iloperidone—Dermatitis—Memantine—Alzheimer's disease	0.000113	0.000872	CcSEcCtD
Iloperidone—Rash—Rivastigmine—Alzheimer's disease	0.00011	0.000854	CcSEcCtD
Iloperidone—Dermatitis—Rivastigmine—Alzheimer's disease	0.00011	0.000853	CcSEcCtD
Iloperidone—Nausea—Memantine—Alzheimer's disease	0.000106	0.000823	CcSEcCtD
Iloperidone—Nausea—Rivastigmine—Alzheimer's disease	0.000104	0.000805	CcSEcCtD
Iloperidone—HTR2A—brain—Alzheimer's disease	0.000104	0.00179	CbGeAlD
Iloperidone—CYP2D6—brain—Alzheimer's disease	9.44e-05	0.00163	CbGeAlD
Iloperidone—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	2.77e-06	4.48e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	2.76e-06	4.47e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	2.76e-06	4.47e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	2.76e-06	4.46e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PPARG—Alzheimer's disease	2.75e-06	4.45e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	2.74e-06	4.44e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	2.74e-06	4.43e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—F2—Alzheimer's disease	2.73e-06	4.43e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.73e-06	4.42e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	2.73e-06	4.42e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—F2—Alzheimer's disease	2.73e-06	4.42e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.72e-06	4.4e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	2.71e-06	4.39e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—INS—Alzheimer's disease	2.69e-06	4.36e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.69e-06	4.36e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	2.68e-06	4.34e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.68e-06	4.34e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.68e-06	4.34e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.68e-06	4.34e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	2.68e-06	4.33e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.67e-06	4.33e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.67e-06	4.32e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	4.31e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	2.65e-06	4.29e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.65e-06	4.29e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	2.65e-06	4.28e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.64e-06	4.28e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	2.64e-06	4.28e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	2.64e-06	4.27e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.64e-06	4.27e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.64e-06	4.27e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.63e-06	4.26e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.62e-06	4.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.62e-06	4.24e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.61e-06	4.23e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.56e-06	4.15e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.55e-06	4.13e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.53e-06	4.1e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.53e-06	4.1e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.53e-06	4.1e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.53e-06	4.09e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PPARG—Alzheimer's disease	2.52e-06	4.08e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.52e-06	4.08e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	2.52e-06	4.08e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.52e-06	4.07e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.51e-06	4.07e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.51e-06	4.06e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.5e-06	4.06e-05	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.5e-06	4.06e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.5e-06	4.05e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.49e-06	4.03e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.49e-06	4.03e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.48e-06	4.02e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.48e-06	4.02e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.47e-06	4.01e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.47e-06	4.01e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—INS—Alzheimer's disease	2.47e-06	4.01e-05	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.47e-06	4e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.47e-06	4e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—INS—Alzheimer's disease	2.47e-06	4e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.46e-06	3.99e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.46e-06	3.98e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.45e-06	3.97e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.45e-06	3.96e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2.45e-06	3.96e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2.44e-06	3.96e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.44e-06	3.95e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.43e-06	3.94e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.43e-06	3.93e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.42e-06	3.93e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.4e-06	3.89e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.4e-06	3.89e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.39e-06	3.88e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.39e-06	3.87e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.38e-06	3.86e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.36e-06	3.83e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.35e-06	3.81e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.34e-06	3.8e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	2.34e-06	3.79e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.28e-06	3.7e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.28e-06	3.69e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.28e-06	3.69e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.27e-06	3.68e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.27e-06	3.68e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.26e-06	3.67e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.25e-06	3.65e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	2.25e-06	3.64e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.24e-06	3.64e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	2.24e-06	3.63e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	2.24e-06	3.63e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.23e-06	3.62e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	2.23e-06	3.61e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.22e-06	3.59e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.21e-06	3.57e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.21e-06	3.57e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.18e-06	3.53e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.17e-06	3.52e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.17e-06	3.51e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.17e-06	3.51e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.16e-06	3.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.16e-06	3.5e-05	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.15e-06	3.49e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	2.15e-06	3.48e-05	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.14e-06	3.47e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.13e-06	3.45e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.13e-06	3.44e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.12e-06	3.44e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.12e-06	3.43e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-06	3.41e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.11e-06	3.41e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.1e-06	3.41e-05	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.08e-06	3.37e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	2.08e-06	3.36e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.08e-06	3.36e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	2.06e-06	3.34e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.06e-06	3.34e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.05e-06	3.33e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	2.05e-06	3.32e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.04e-06	3.31e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.03e-06	3.3e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.98e-06	3.21e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.98e-06	3.21e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.97e-06	3.2e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.96e-06	3.18e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-06	3.17e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.95e-06	3.16e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.94e-06	3.15e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.93e-06	3.13e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.91e-06	3.09e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.9e-06	3.07e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.89e-06	3.06e-05	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.89e-06	3.06e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.87e-06	3.03e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.87e-06	3.03e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.86e-06	3.01e-05	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.86e-06	3.01e-05	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.86e-06	3.01e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.85e-06	2.99e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.85e-06	2.99e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.84e-06	2.98e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.84e-06	2.98e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.83e-06	2.97e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.83e-06	2.97e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.83e-06	2.96e-05	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.82e-06	2.95e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.81e-06	2.93e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.8e-06	2.92e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.8e-06	2.92e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.79e-06	2.9e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.79e-06	2.9e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.77e-06	2.86e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.76e-06	2.85e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—INS—Alzheimer's disease	1.75e-06	2.84e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.75e-06	2.84e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.75e-06	2.84e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.75e-06	2.83e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.74e-06	2.82e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.72e-06	2.79e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.72e-06	2.79e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.72e-06	2.78e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.69e-06	2.73e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.68e-06	2.72e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	2.72e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	2.7e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-06	2.69e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-06	2.69e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.65e-06	2.68e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-06	2.68e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.62e-06	2.62e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.61e-06	2.6e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.6e-06	2.6e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.59e-06	2.58e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-06	2.57e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.57e-06	2.54e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.56e-06	2.53e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.56e-06	2.53e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.56e-06	2.53e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.56e-06	2.52e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.55e-06	2.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.54e-06	2.5e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.54e-06	2.49e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	2.49e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.53e-06	2.48e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.52e-06	2.45e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.49e-06	2.42e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—INS—Alzheimer's disease	1.49e-06	2.41e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-06	2.36e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.46e-06	2.36e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.44e-06	2.34e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.44e-06	2.33e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.44e-06	2.32e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.43e-06	2.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.42e-06	2.3e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	2.28e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-06	2.28e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.38e-06	2.23e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	2.22e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.36e-06	2.2e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.35e-06	2.18e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.34e-06	2.18e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.34e-06	2.18e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.34e-06	2.16e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.33e-06	2.16e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.33e-06	2.15e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.32e-06	2.14e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	2.11e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.3e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	2.03e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	2.02e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.21e-06	1.96e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	1.94e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.19e-06	1.93e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.18e-06	1.91e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.18e-06	1.91e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.17e-06	1.89e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	1.87e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.87e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—INS—Alzheimer's disease	1.15e-06	1.86e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.12e-06	1.81e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	1.78e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.09e-06	1.76e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.08e-06	1.75e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.08e-06	1.75e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	1.74e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.06e-06	1.72e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.01e-06	1.64e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.01e-06	1.63e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	9.98e-07	1.62e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—Alzheimer's disease	9.97e-07	1.61e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	9.95e-07	1.61e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	9.95e-07	1.61e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	9.84e-07	1.59e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	9.77e-07	1.58e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	9.2e-07	1.49e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	9.08e-07	1.47e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	7.07e-07	1.15e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.99e-07	9.71e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.62e-07	7.49e-06	CbGpPWpGaD
